Office of Research on Women's Health
A renowned scientist of the Karolinska Institute in Stockholm, Sweden, Jan-Ake Gustafsson, M.D., Ph.D., will open the symposium with a discussion of estrogen receptors and new developments revitalizing the entire field of estrogen action. Deborah Grady, M.D., M.P.H., of the University of California-San Francisco, will then provide a presentation more clinical in nature reviewing what we have learned in the last decade about postmenopausal hormone replacement therapy for preventing disease.
Other presentations will bring remarks from Jacques Rossouw, M.D., Acting Director of the Women's Health Initiative, National Heart, Lung and Blood Institute (NHLBI), on the interface of research, biology and best clinical practices. Susan R. Johnson, M.D., of the University of Iowa, will discuss the implications of research on the clinical care of women. Anne L. Taylor, M.D., of the University of Minnesota, will moderate this discussion. Concluding remarks, "Women's Health and Menopause: Future Needs A Research Agenda for the New Millennium," will be provided by Nanette Wenger, M.D., of Emory University.
"I am excited over the breadth of national and international expertise of our symposium participants," says Vivian W. Pinn, M.D., Director of ORWH. "These experts will provide a tremendous opportunity for information sharing about both basic and clinical research determinants of current and future clinical management of menopause."
The "International Position Paper on Women's Health and Menopause" is the result of a cooperative venture of NHLBI and ORWH at NIH and the Giovanni Lorenzini Medical Science Foundation in Milan, Italy, and Houston, Texas. This project was designed to introduce a new interdisciplinary perspective on the growing field of research represented by menopause in every part of the world. Copies of the summary chapter, "Best Clinical Practice: A Comprehensive Approach," will be provided by NHLBI and distributed at the symposium.
Established on September 10, 1990, in the Office of the Director of NIH, ORWH became the first office in the Public Health Service dedicated specifically to women's health and research. ORWH is the focal point at NIH for women's health research, ensuring inclusion in clinical trials and the development of programs to advance women in biomedical careers. The Annual Lectureship on Women's Health Research, instituted during the scientific celebration of the 10th anniversary of ORWH, is free and open to the public. Attached is the agenda for the lectureship. The program also may be viewed online at http://videocast.nih.gov.
Speakers will be available to reporters following the lectureship. For information on location for these interviews, contact Ellyn Pollack at 301-402-1770.
"From Estrogen Receptors to Management of Menopause"
Sponsored by the NIH Office of Research on Women's Health
Jack Masur Auditorium, Warren Grant Magnuson Clinical Center
National Institutes of Health
Friday, March 22, 2002
9 a.m. - noon
Biology, Biostatistics, and Best Practices
Jacques E. Rossouw, M.D.
Acting Director, Women's Health Initiative
National Heart, Lung, & Blood Institute, NIH
The NIH Giovanni Lorenzini Medical Foundation Joint Effort for the
Preparation of the "International Position Paper on Women's Health and
Professor Rodolfo Paoletti, M.D., Ph.D.
President, Fondazione Giovanni Lorenzini Medical Science Foundation
Milan, Italy Houston, Texas
From Clinical Trials to the Annual Exam: How Can Clinicians Keep
Science in the Conversation Without Creating Chaos for Their Patients?
Susan R. Johnson, M.D.
Professor of Obstetrics and Gynecology, and Epidemiology
Colleges of Medicine and Public Health, University of Iowa
The International Position Paper on Women's Health and Menopause will be introduced during this symposium. The summary chapter, "Best Clinical Practice: A Comprehensive Approach," will be distributed. Consultant, Emory Heart and Vascular Center.